Clinical Trial Update: Safety Study of CADI-05 in Patients With Advanced Stage Melanoma [Phase 1, Phase 2]

View source ↗

Summary

The safety study of CADI-05 in patients with advanced-stage melanoma has been terminated (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• CADI-05

Snippet

Sponsor: Cadila Pharnmaceuticals | Conditions: Stage III or Stage IV Melanoma | Phase 1, Phase 2 | Status: TERMINATED